理解黑种人与白种人乳腺癌死亡率差距的驱动因素：呼吁更有力的定义。
Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions.
机构信息
Department of Surgery, Division of Breast Surgery, City of Hope, Duarte, California.
Department of Surgery, City of Hope, Duarte, California.
出版信息
Cancer. 2022 Jul 15;128(14):2695-2697. doi: 10.1002/cncr.34243. Epub 2022 May 17.
Abstract
Kim et al completed a pooled analysis of 8 National Surgical Adjuvant Breast and Bowel Project trials and highlight that, when compared with White patients, Black patients with estrogen receptor–positive (ER+) breast cancer have worse distant recurrence‐free survival, especially in the setting of neoadjuvant chemotherapy when pathologic complete response is not achieved. This editorial highlights that, to comprehend the drivers of this disparity, we must have more robust definitions of ER+ breast cancer and race.
摘要
金等人对 8 项美国国家癌症综合网络外科辅助乳腺与肠道项目试验进行了汇总分析，强调与白人患者相比，雌激素受体阳性（ER+）乳腺癌黑人患者的远处无复发生存更差，尤其是在未达到病理完全缓解的新辅助化疗环境下。这篇社论强调，为了理解这种差异的驱动因素，我们必须对 ER+乳腺癌和种族有更严格的定义。
相似文献
1
Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions.理解黑种人与白种人乳腺癌死亡率差距的驱动因素：呼吁更有力的定义。
Cancer. 2022 Jul 15;128(14):2695-2697. doi: 10.1002/cncr.34243. Epub 2022 May 17.
2
Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses.按雌激素受体和孕激素受体状态分层的黑人和白人妇女的乳腺癌发病率。
PLoS One. 2012;7(11):e49359. doi: 10.1371/journal.pone.0049359. Epub 2012 Nov 14.
3
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.激素受体、HER2 和 p53 状态对浸润性乳腺癌黑人女性和白人女性死亡率的影响。
BMC Cancer. 2013 May 4;13:225. doi: 10.1186/1471-2407-13-225.
4
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.白人女性和黑人女性中雌激素受体表达与乳腺癌特异性死亡风险的定量测量。
Breast Cancer Res. 2013;15(5):R90. doi: 10.1186/bcr3486.
5
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.雌激素和孕激素受体阳性乳腺癌患者生存的种族差异：对降低乳腺癌死亡率差异的启示
Breast Cancer Res Treat. 2017 Jun;163(2):321-330. doi: 10.1007/s10549-017-4166-z. Epub 2017 Mar 1.
6
The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).绝经对雌激素受体阴性（ER-）乳腺癌发病率的影响大于雌激素受体阳性（ER+）乳腺癌：一种可能的解释（美国）
Cancer Causes Control. 2002 Feb;13(1):7-14. doi: 10.1023/a:1013960609008.
7
Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors.社会经济地位和生殖因素对雌激素/孕激素受体阴性乳腺癌种族和民族差异的介导作用
Am J Epidemiol. 2016 May 15;183(10):884-93. doi: 10.1093/aje/kwv226. Epub 2016 Apr 13.
8
Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.按雌激素受体和孕激素受体状态分析，乳腺癌诊断后生存的种族/民族差异：一项汇总分析。
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):351-363. doi: 10.1158/1055-9965.EPI-20-1291. Epub 2020 Dec 18.
9
A comparison of estrogen and progesterone receptors in black and white breast cancer patients.黑人和白人乳腺癌患者雌激素和孕激素受体的比较。
Am J Public Health. 1987 Mar;77(3):351-3. doi: 10.2105/ajph.77.3.351.
10
Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.炎症状态和激素受体状态下乳腺癌生存的种族/民族差异：基于监测、流行病学和最终结果数据的分析
Cancer Causes Control. 2014 Aug;25(8):959-68. doi: 10.1007/s10552-014-0395-1. Epub 2014 May 17.
引用本文的文献
1
Prescription and self-reported use of endocrine therapy among black hormone receptor-positive breast cancer survivors in the Detroit Research on Cancer Survivors cohort.底特律癌症幸存者队列研究中黑人激素受体阳性乳腺癌幸存者内分泌治疗的处方使用情况及自我报告使用情况
Breast Cancer Res Treat. 2025 Sep 9. doi: 10.1007/s10549-025-07816-1.
2
Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer.《外科肿瘤学年鉴》标志性系列：外科肿瘤学中的差异——乳腺癌
Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18157-0.
3
Clinical and Multiomic Features Differentiate Young Black and White Breast Cancer Cohorts Derived by Machine Learning Approaches.临床和多组学特征区分通过机器学习方法得出的年轻黑人和白人乳腺癌队列。
Clin Breast Cancer. 2025 Apr;25(3):e301-e311. doi: 10.1016/j.clbc.2024.11.015. Epub 2024 Nov 28.
4
An Investigation into Race Bias in Random Forest Models Based on Breast DCE-MRI Derived Radiomics Features.基于乳腺动态对比增强磁共振成像衍生的影像组学特征对随机森林模型中的种族偏见进行的调查。
Clin Image Based Proced Fairness AI Med Imaging Ethical Philos Issues Med Imaging (2023). 2023;14242:225-234. doi: 10.1007/978-3-031-45249-9_22. Epub 2023 Oct 9.
5
Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.年龄、体重指数、肿瘤亚型以及乳腺癌生存中的种族和民族差异。
JAMA Netw Open. 2023 Oct 2;6(10):e2339584. doi: 10.1001/jamanetworkopen.2023.39584.
本文引用的文献
1
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials.局部乳腺癌患者远处无复发生存的种族差异：国家外科辅助乳腺和肠道项目试验的汇总分析。
Cancer. 2022 Jul 15;128(14):2728-2735. doi: 10.1002/cncr.34241. Epub 2022 May 17.
2
Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer.乳腺癌新辅助化疗后病理完全缓解的种族/民族差异及趋势
Cancers (Basel). 2022 Jan 21;14(3):534. doi: 10.3390/cancers14030534.
3
Calling Attention to the Role of Race-Driven Societal Determinants of Health on Aggressive Tumor Biology: A Focus on Black Americans.呼吁关注种族驱动的社会健康决定因素在侵袭性肿瘤生物学中的作用：以美国黑人为重点。
JCO Oncol Pract. 2022 Jan;18(1):15-22. doi: 10.1200/OP.21.00297. Epub 2021 Jul 13.
4
Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism.医学中的种族与遗传血统——正视种族主义的时刻
N Engl J Med. 2021 Feb 4;384(5):474-480. doi: 10.1056/NEJMms2029562. Epub 2021 Jan 6.
5
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.在 2 期和 3 期乳腺癌新辅助治疗中，个体水平病理完全缓解与无事件生存和远处无复发生存的相关性：I-SPY2 适应性随机临床试验的 3 年随访分析。
JAMA Oncol. 2020 Sep 1;6(9):1355-1362. doi: 10.1001/jamaoncol.2020.2535.
6
Breast cancer statistics, 2019.乳腺癌统计数据，2019 年。
CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.
7
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience.789 例早期和局部晚期乳腺癌患者新辅助全身治疗的病理完全缓解：皇家马斯登医院的经验。
Breast Cancer Res Treat. 2020 Jan;179(1):101-111. doi: 10.1007/s10549-019-05444-0. Epub 2019 Sep 18.
8
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.2008年至2018年导致癌症药物获批的临床试验中种族报告与代表性的差异
JAMA Oncol. 2019 Oct 1;5(10):e191870. doi: 10.1001/jamaoncol.2019.1870. Epub 2019 Oct 10.
9
Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.血统作为哥伦比亚女性乳腺肿瘤中基因表达的潜在调节因素。
PLoS One. 2017 Aug 23;12(8):e0183179. doi: 10.1371/journal.pone.0183179. eCollection 2017.
10
Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.田纳西州孟菲斯市非裔美国女性中不同乳腺肿瘤亚型生存结果的种族差异。
Cancer Med. 2017 Jul;6(7):1776-1786. doi: 10.1002/cam4.1117. Epub 2017 Jun 14.
Zotero 插件